Literature DB >> 11954891

Combined autoimmune disease in a patient with AIDS.

G Zandman-Goddard1, E Peeva, P Barland.   

Abstract

Immune dysregulation in HIV-infected patients, along with the new medications for treatment of AIDS that possess immunomodulating potential, may lead to an increased incidence of autoimmune diseases in this patient population. However, the presence of combined autoimmune diseases in an AIDS patient is rare. Relapsing polychondritis (RP) is an uncommon inflammatory disease manifested by recurrent attacks of auricular chondritis. The presence of type II and IX collagen antibodies, and their association with HLA-DR4 and other autoimmune diseases, suggests that antiself reactions may be present. Sarcoidosis is a granulomatous disease manifested by inflammation of the lungs, eyes and joints. In the peripheral blood there is depressed cellular immunity and enhanced humoral immunity. We here describe a case of coexisting RP and sarcoidosis in an AIDS patient.

Entities:  

Mesh:

Year:  2002        PMID: 11954891     DOI: 10.1007/s100670200017

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  4 in total

Review 1.  Rheumatic manifestations of human immunodeficiency virus.

Authors:  Alan M Solinger
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

2.  [Neurological complications of HIV infection].

Authors:  G Arendt; T Nolting
Journal:  Nervenarzt       Date:  2008-12       Impact factor: 1.214

3.  Coexisting relapsing polychondritis and sarcoidosis: an unusual association.

Authors:  Florian Pasquet; Vincent Cottin; Nadia Sivova; Julie Le Scanff; Christiane Broussolle; Pascal Sève
Journal:  Rheumatol Int       Date:  2009-08-28       Impact factor: 2.631

Review 4.  Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management.

Authors:  Devesh J Dhasmana; Keertan Dheda; Pernille Ravn; Robert J Wilkinson; Graeme Meintjes
Journal:  Drugs       Date:  2008       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.